Anticoagulant therapy for infertility in women aged 20-45
Part of Women’s health & pregnancy clinical trials.
This study looks at whether blood-thinning medication can improve the chance of pregnancy in women who have trouble conceiving. It focuses on how the medication affects the lining of the womb and its ability to accept an embryo.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 20 and 45 years old.
- You have been diagnosed with infertility and plan to have an embryo transfer or timed conception cycles.
- You have complete medical records and are willing to have special ultrasound exams to check your womb lining.
- You agree to take part in this study and sign a consent form.
- You do not have any serious womb shape problems, untreated large fibroids, severe scarring, or polyps inside the womb.
- You do not have serious illnesses like severe liver or kidney disease, or cancer, and you do not have a bleeding disorder that prevents using blood thinners.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if atosiban, a medicine that relaxes the uterus, can help women who have had multiple failed embryo transfers. It's for women whose uterus has abnormal contractions, which might prevent embryos from implanting.
This trial tests whether taking prednisone (a steroid) and aspirin (a blood thinner) before embryo transfer improves pregnancy rates in women with thyroid antibodies. If you have these antibodies and are doing IVF, this could help reduce inflammation and improve your chances.
This study looks at how your blood clots (and clotting proteins) behave around ovarian stimulation for infertility care. It may help researchers understand clot-related risks and improve how treatment is monitored.
This Phase 3 study tests whether daily low-dose aspirin can reduce the risk of preeclampsia (dangerous high blood pressure in pregnancy) and improve pregnancy outcomes for people who got pregnant using assisted reproduction like IVF. It mainly targets pregnancies early on (about 9–14 weeks).
This trial tests whether taking baby-dose aspirin after a frozen embryo transfer can lower the chance of developing pre-eclampsia, a blood-pressure problem that can happen during pregnancy. It targets women considered at higher risk based on specific health factors and pregnancy details.
This trial studies whether platelet-rich plasma (PRP) can help grow a thin uterine lining enough to support a pregnancy. It is aimed at people who have had repeated unsuccessful frozen embryo transfers and had a lining of 6 mm or less.
Hear when a new Infertility trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.